APA

van der Veer A., van der Velden V. H. J., Willemse M. E., Hoogeveen P. G., Petricoin E. F., Beverloo H. B., Escherich G., Horstmann M. A., Pieters R. & den Boer M. L. (20140217). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. : Blood cancer journal.

Chicago

van der Veer A, van der Velden V H J, Willemse M E, Hoogeveen P G, Petricoin E F, Beverloo H B, Escherich G, Horstmann M A, Pieters R and den Boer M L. 20140217. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. : Blood cancer journal.

Harvard

van der Veer A., van der Velden V. H. J., Willemse M. E., Hoogeveen P. G., Petricoin E. F., Beverloo H. B., Escherich G., Horstmann M. A., Pieters R. and den Boer M. L. (20140217). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. : Blood cancer journal.

MLA

van der Veer A, van der Velden V H J, Willemse M E, Hoogeveen P G, Petricoin E F, Beverloo H B, Escherich G, Horstmann M A, Pieters R and den Boer M L. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. : Blood cancer journal. 20140217.